导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.74% | 3379/4763 |
| 近一周 | -4.10% | 4992/5452 |
| 近一月 | -3.64% | 2705/5409 |
| 近一季 | 2.11% | 620/5219 |
| 近半年 | -10.74% | 3704/4908 |
| 近一年 | -8.59% | 3315/4388 |
| 近两年 | 30.66% | 2247/2951 |
| 近三年 | -4.97% | 1986/2250 |
| 成立以来 | 51.35% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.15% 1715/4961 |
-6.26% 3680/5312 |
- - |
- - |
| 2025 | 10.00% 2841/4813 |
-0.10% 2058/3635 |
3.53% 998/4076 |
9.92% 3328/4524 |
-3.24% 3260/4813 |
| 2024 | -6.85% 2293/3463 |
-8.58% 2237/2808 |
-9.96% 2406/3014 |
14.73% 1919/3129 |
-1.36% 1667/3463 |
| 2023 | -13.45% 1543/2656 |
0.74% 1707/2280 |
-7.36% 1845/2385 |
-4.75% 1213/2515 |
-2.63% 500/2655 |
| 2022 | -20.40% 970/2207 |
-11.54% 526/1919 |
-0.17% 1603/2016 |
-13.34% 887/2113 |
4.02% 605/2208 |
| 2021 | 4.41% 578/1822 |
0.45% 294/1255 |
4.27% 905/1330 |
-2.65% 587/1466 |
2.40% 605/1822 |
| 2020 | 69.37% 76/1250 |
13.56% 8/1028 |
33.21% 30/1067 |
10.99% 491/1164 |
0.88% 1047/1184 |
| 2019 | 44.86% 164/1092 |
37.64% 74/754 |
-3.25% 380/804 |
4.23% 210/850 |
4.37% 806/918 |
| 2018 | -26.83% 404/834 |
- - |
- - |
- - |
-13.00% 501/691 |
| 2017 | 2.19% 443/714 |
- - |
- - |
- - |
- - |
| 2016 | -11.78% 295/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 前海开源中证健康产业指数 VS. 长安沪深300非周期A(740101) |